Related Experiment Video
Updated: May 1, 2026

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression
Published on: April 10, 2026
Does group cognitive-behavioral therapy module type moderate depression symptom changes in substance abuse treatment
Susan M Paddock1, Sarah B Hunter1, Thomas J Leininger2
1RAND Corporation, Santa Monica, CA 90407.
Abstract:
Little is known about the effect of group therapy treatment modules on symptom change during treatment and on outcomes post-treatment. Secondary analyses of depressive symptoms collected from two group therapy studies conducted in substance use treatment settings were examined (n=132 and n=44). Change in PHQ-9 scores was modeled using longitudinal growth modeling combined with random effects modeling of session effects, with time-in-treatment interacted with module theme to test moderation. In both studies, depressive symptoms significantly decreased during the active treatment phase. Symptom reductions were not significantly moderated by module theme in the larger study. However, the smaller pilot study's results suggest that future examination of module effects is warranted, given the data are compatible with differential reductions in reported symptoms being associated with attending people-themed module sessions versus thoughts-themed sessions.
Related Concept Videos
Cognitive Therapy
Group Therapy
Drug Therapy
Antianxiety Medications
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Drug Dependence
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
